Diabetic Peripheral Neuropathic Pain (DPNP)
4
2
3
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
11 treatments under study, led by Lymphovenous Bypass At Diseased Foot Dorsum
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
50%
2 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Randomized, Double-blind, Placebo-controlled, Multicenter Phase IIb Clinical Trial of Spray YJ001 for the Treatment of Diabetic Peripheral Neuropathic Pain
YJ001 Spray for Diabetic Peripheral Neuropathic Pain
Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain
Using Lymphovenous Bypass to Alleviate Diabetic Peripheral Neuropathy
Research Network
Common Treatments
- Lymphovenous Bypass At Diseased Foot Dorsum1
- Yj001 Spray1
- Yj001 Spray Simulator1
- Pregabalin1
- Mirogabalin1
Active Sponsors
- Zhejiang Yuejia Pharmaceuticals Co., Ltd.1
- National Taiwan University Hospital1
- Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.1
- Bangladesh Medical University1
Top Investigators
Bangladesh Medical University
Related Conditions
- Diabetic Foot Ulcer1
- Diabetic Peripheral Neuropathy Dpn1